ETHZilla Corp — Director's Dealing 2023

Jun 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2023-05-31

Reporting Person: McGovern Jr. Donald A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-31	Common Stock	P	10000	$1.147	Acquired	30099	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $1.13 to $1.15, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.